Compositions and methods for delivering syntaxin-binding protein-1

TW202635893APending Publication Date: 2026-09-01NEUROCRINE BIOSCIENCES INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114141894
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-10-30
Filing Date
2025-10-29
Publication Date
2026-09-01

Smart Images

  • Figure TWG2TA001074532_001
    Figure TWG2TA001074532_001
  • Figure TWG2TA001074532_002
    Figure TWG2TA001074532_002
  • Figure TWG2TA001074532_003
    Figure TWG2TA001074532_003
Patent Text Reader

Abstract

The disclosure relates to polynucleotides, e.g., viral genomes, encoding syntaxin-binding protein-1 (STXBP1), vectors, e.g., adeno-associated virus (AAV) particles, comprising said polynucleotides, compositions comprising said polynucleotides or vectors, and methods of making or delivering to a cell or subject. The polynucleotides, vectors, compositions, and methods of the present disclosure are useful for the treatment of subjects who have, have been diagnosed with having, or are at risk of having a STXBP1-related disorder, e.g., STXBP1 Developmental and Epileptic Encephalopathy (DEE) and / or other STXBP1-related disorders, or at least one symptom thereof.
Need to check novelty before this filing date? Find Prior Art